7 research outputs found
Introduction to the special issue on environmental risk assessment of pharmaceuticals
- Author
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textAccelerating drug development: methodology to support first-in-man pharmacokinetic studies by the use of drug candidate microdosing
- Author
- Publication venue
- 'Wiley'
- Publication date
- 01/01/2007
- Field of study
No full textEffects on prolongation of Bazett’s corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis
- Author
- Albert KK Chung
- American Psychiatric Association (APA)
- Bagnall AM
- Bhattacharjee J
- Canadian Psychiatric Association
- Cochrane Collaboration
- Czekalla J
- European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP)
- European Medicines Agency (EMEA) Committee for Proprietary Medicinal Products
- European Medicines Agency (EMEA) Committee for Proprietary Medicinal Products (CPMP)
- Food and Drug Administration (FDA)
- Food and Drug Administration (FDA)
- Komossa K
- Moher D
- National Institute of Clinical Excellence (NICE)
- National Institute of Clinical Excellence (NICE)
- National Institute of Clinical Excellence (NICE)
- Price LH
- Psychopharmacological Drugs Advisory Committee
- Royal College of Psychiatrists
- Siew-eng Chua
- Welch R
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
No full textNew and emerging technologies for genetic toxicity testing
- Author
- Aardema
- Abramsson-Zetterberg
- Abramsson-Zetterberg
- Amundson
- Asano
- Aubrecht
- Avlasevich
- Baudoin
- Berndt-Weis
- Billinton
- Brennan
- Brennan
- Brennan
- Brodsky
- Bryce
- Bryce
- Bryce
- Burlinson
- Cimino
- Collins
- Collins
- Corvi
- Countryman
- Curren
- Dearden
- Dearfield
- Dearfield
- Dertinger
- Dertinger
- Dertinger
- Dickinson
- ECB (European Chemicals Bureau)
- Ellinger-Ziegelbauer
- EMEA (European Medicines Agency): CHMP (Committee for Medicinal Products for Human Use)
- EMEA (European Medicines Agency): CHMP (Committee for Medicinal Products for Human Use)
- EMEA (European Medicines Agency): CHMP (Committee for Medicinal Products for Human Use)
- EU (European Union)
- Flamand
- Fowler
- Fowler
- Fowler
- Grawé
- Greene
- Harper
- Harrod
- Hartmann
- Hartmann
- Hastwell
- Hastwell
- Health Protection Board (Canada)
- Himmelstein
- Hontzeas
- Hu
- Hu
- Jacobsen
- Jacobsen
- Jacobsen
- Jagger
- Jarabek
- Kanaly
- Kastan
- Kirkland
- Kirkland
- Kirkland
- Kirsch-Volders
- Kirsch-Volders
- Kissling
- Knight
- Kramers
- Ku
- Le Fevre
- Li
- Liebermann
- Lorge
- MacGregor
- Matthews
- Matthews
- Miura
- Miura
- Miura
- Mun
- Muster
- Newton
- Nusse
- Olaharski
- Ostling
- Phonethepswath
- Pottenger
- Reliene
- Rusling
- Rusling
- Shelby
- Shi
- Siafakas
- Singh
- Snyder
- Sofuni
- Stummann
- Tennant
- Thybaud
- Thybaud
- Thybaud
- Tice
- Tometsko
- Torous
- Torous
- Torous
- US FDA (Food and Drug Administration)
- US FDA (Food and Drug Administration)
- US FDA (Food and Drug Administration)
- US FDA (Food and Drug Administration)
- Vickers
- Walmsley
- White
- Witt
- Zeiger
- Zhan
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textBiophysical and Structural Characterization Needed Prior to Proof of Concept
- Author
- Aebersold
- Becktel
- Bielik
- Cantor
- Cao
- Carpenter
- Cole
- European Medicines Agency
- European Medicines Agency Inspections (EMEA) Committee for Medicinal Products for Human Use (CHMP)
- Fan
- Findlay
- Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER)
- Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER).
- Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER).
- Food and Drug Administration (FDA).
- Food and Drug Administration.
- Gabrielson
- Ghaderi
- Guo
- Hara
- Harn
- He
- Houde
- Houde
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
- Jefferis
- Jiskoot
- Jiskoot
- Kiese
- Mach
- Mach
- Medzihradszky
- Narhi
- Ogle
- Philo
- Putnam
- Remmele
- Riggs
- Rohrer
- Rosenberg
- Rustgi
- Salas-Salano
- Seidler
- Sharma
- Singh
- Stroop
- Thoma
- United States Food and Drug Administration
- Walsh
- Wiesner
- Yang
- Zaher
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textHigh-throughput wide dynamic range procedure for the simultaneous quantification of nicotine and cotinine in multiple biological matrices using hydrophilic interaction liquid chromatography-tandem mass spectrometry
- Author
- A Florescu
- BK Matuszewski
- BM Fonseca da
- CF Wu
- CN Man
- DM Shakleya
- E Avila-Tang
- E White
- EI Miller
- Esteve Fernández
- Eurachem
- European Medicines Agency (EMEA) Science Medicines Health, Committee for Medicinal Products for Human Use (CHMP)
- F Kardani
- F Marclay
- G Ortega
- G Ortega
- GN Mahoney
- H Kataoka
- H Wang
- H Wang
- I Kim
- JA Pascual
- JM MartĂnez-Sánchez
- Jose M. MartĂnez-Sánchez
- José A. Pascual
- JT Bernert Jr
- L Gruer
- M Ballbè
- M Fu
- M Meger
- M Pellegrini
- M Piller
- MC Bentley
- NL Benowitz
- NL Benowitz
- OA Ghosheh
- P Jacob 3rd
- P Kintz
- Raúl Pérez-Ortuño
- SE Murphy
- Society of Forensic Toxicologists (SOFT) Inc., American Academy of Forensic Sciences (AAFS), Toxicology Section
- Substance Abuse and Mental Health Services Administration (SAMHSA) Department of Health and Human Services
- T Ino
- T Tuomi
- T Uematsu
- TJ Smyth
- TP Moyer
- U.S. Department of Health and Human Services Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM)
- US Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health
- WK Al-Delaimy
- Word Health Organization (WHO)
- X Sureda
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
No full textDrug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies
- Author
- Anandatheerthavarada
- Aninat
- Ashrafian
- Bae
- Ballet
- Baty
- Begriche
- Belay
- Bellentani
- Beltrand
- Berson
- Berson
- Berson
- Blackard
- Brookes
- Bruno
- Cahill
- Callery
- Carmiel-Haggai
- Chabrol
- Chen
- Chiarugi
- Chitturi
- Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA)
- Coquard
- Danan
- de Vries
- Degoul
- Demeilliers
- Deschamps
- Deschamps
- Dianov
- Dixit
- Dykens
- Farrell
- Fau
- FDA Working Group
- Feldmann
- Fernandez
- Fernandez-Checa
- Frneaux
- Fromenty
- Fromenty
- Fromenty
- Fromenty
- Fromenty
- Fromenty
- Fromenty
- Gardner
- Genve
- Gougeon
- Guillouzo
- Gunawan
- Hamada
- Haouzi
- Huang
- Hynes
- Igoudjil
- Igoudjil
- Igoudjil
- James
- Kaplowitz
- Kennedy
- Kim
- Knapp
- Korenaga
- Krhenbhl
- Langman
- Larosche
- Le Dinh
- Lebrecht
- Lee
- Lehninger
- Lettron
- Lewis
- Lewis
- Maaswinkel-Mooij
- Mansouri
- Marroquin
- Masubuchi
- Masubuchi
- Masubuchi
- Matsuhashi
- Matsuhashi
- McCarthy
- Moraes
- Moreira
- Murayama
- Nadanaciva
- Nadanaciva
- Nahon
- Navarro
- Neuman
- Nicotera
- Nishida
- Njolstad
- Novak
- Oakes
- Ong
- Ong
- Ozawa
- Park
- Pessayre
- Pessayre
- Pessayre
- Pessayre
- Peters
- Piccoli
- Prip-Buus
- Rahmani
- Richardson
- Rinaldo
- Robin
- Robin
- Rodriguez
- Salway
- Scatena
- Sepuri
- Sim
- Spaniol
- Stphenne
- Sugimoto
- Sutton
- Sutton
- Sutton
- Talwani
- Tanaka
- Tarantino
- Tennant
- Tomaru
- Tomita
- Treem
- Trost
- Ulrich
- Ulrich
- Vauthey
- Velsor
- Vittecoq
- Walker
- Weis
- Williams
- Yamanaka
- Yerushalmi
- Zoratti
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full text
